

Get a Snapshot of the Early Stage Life Science Startup Landscape
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.

7 Things Employers Should Be Doing to Fulfill Their Fiduciary Duty
Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert.

What Does HHS’ Restructuring Mean for Interoperability In Healthcare?
Experts say the fallout from HHS’ restructuring could set public health efforts back by decades by dismantling critical infrastructure. It’s also important to note that these changes cast serious doubt on the future of interoperability, pointed out Jason Prestinario, CEO of data platform Particle Health.

Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect
Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics.

How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration
Health insurance claims are a growing headache for providers; many say their employers could do more to help them address the daily demands of insurers